MktsMarkets

Sutro Biopharma, Inc.
NASDAQ: STROKey statistics
STRO News
Stories mentioning STRO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 14,523 | 11,647 | 9,693 | 63,745 | 17,399 | 14,809 | 8,520 | 25,706 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 36,553 | 36,642 | 39,853 | 38,325 | 51,597 | 71,037 | 62,108 | 62,020 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 44,179 | 49,696 | 58,152 | 67,090 | 85,913 | 80,067 | 76,439 | 74,391 |
| Operating Income (Loss) | (29,656) | (38,049) | (48,459) | (3,345) | (68,514) | (65,258) | (67,919) | (48,685) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (38,499) | (46,844) | (56,857) | (11,517) | (75,961) | (70,088) | (48,787) | (48,010) |
| Tax Provision | (15.00) | (82.00) | 0.00 | (18.00) | 7.00 | 0.00 | 8.00 | |
| Net Income (Loss) | (38,484) | (46,762) | (56,857) | (11,499) | (75,968) | (72,443) | (48,787) | (48,018) |
| Earnings Per Share (Basic) | (2.94) | (5.50) | (0.67) | (0.14) | (9.08) | (9.36) | (0.59) | (0.59) |
| Earnings Per Share (Diluted) | (2.94) | (5.50) | (0.67) | (0.14) | (9.08) | (9.36) | (0.59) | (0.59) |
| Weighted Average Shares Outstanding (Basic) | 13,082 | 8,498 | 84,870 | 84,580 | 8,364 | 7,737 | 82,044 | 81,225 |
| Weighted Average Shares Outstanding (Diluted) | 13,082 | 8,498 | 84,870 | 84,580 | 8,364 | 7,737 | 82,044 | 81,225 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About STRO
Sutro Biopharma, Inc. (NASDAQ: STRO) is a stock listed on the Nasdaq Stock Market under the ticker symbol STRO. It last traded at $9.62 (Nov 6, 2026, 4:00 PM ET), up 4.6% on the day. That gives Sutro Biopharma a market capitalisation of $159.5M.
Over the past 52 weeks STRO has traded between $7.15 and $43.85.
Revenue for the quarter ended Mar 31, 2026 was $14.5M; a net loss of $38.5M. Revenue was down 16.5% from $17.4M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $14.5M | -$38.5M | -265.0% |
| Dec 31, 2025 | $11.6M | -$46.8M | -401.5% |
| Sep 30, 2025 | $9.7M | -$56.9M | -586.6% |
| Jun 30, 2025 | $63.7M | -$11.5M | -18.0% |
From Sutro Biopharma’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…